Position in ALXO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,162,585
+$2,162,387 QoQ
Shares Held
1,044,728
+1055180.8% QoQ
Ownership
0.756%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 94 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. ALXO ranks #148 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in ALXO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,162,585 | 1,044,728 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $198 | 99 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $111 | 99 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $113,275 | 61,899 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $36,665 | 88,352 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $223,006 | 357,957 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $394,195 | 236,046 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $74,498 | 40,934 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $243,761 | 40,425 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $467,150 | 41,897 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $708,509 | 47,583 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $104,327 | 21,735 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $139,355 | 18,556 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $80,487 | 17,807 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $150,094 | 13,416 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $139,538 | 14,581 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $108,631 | 13,428 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $325,104 | 19,237 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $339,970 | 15,820 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,109,966 | 15,028 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $675,022 | 12,345 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $732,385 | 9,932 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $439,100 | 5,094 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $134,656 | 3,568 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||